Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • ICIJ Implant Files:...

    ICIJ Implant Files: Medtronic allegedly linked to many breaches

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-27T13:23:06+05:30  |  Updated On 27 Nov 2018 1:23 PM IST
    ICIJ Implant Files: Medtronic allegedly linked to many breaches




    Washington: A world leader in medical technology, the American firm Medtronic, may be linked to as many as 9,300 deaths and 292,000 injuries in the US alone, according to an analysis published Sunday by an international journalists' group.

    Reports submitted to US regulators last year indicate that one in five medical implants using Medtronic products proved problematic, twice the rate of any competing firm, according to a wide-reaching analysis by the International Consortium of Investigative Journalists (ICIJ).

    The ICIJ inquiry, titled "Implant Files" and drawing on contributions from reporters in 36 countries, found that authorities in Japan, Norway and Australia had also identified Medtronic products as the source of the largest numbers of complaints over the past five years.

    Among the findings: Since 2008, insulin pumps or their component parts produced by Medtronic for diabetics have been potentially implicated in more than 2,600 deaths and 150,000 injuries in the US.

    ICIJ reporters interviewed patients or family members of victims in Finland, Germany, Canada, India and the United States who said Medtronic was slow to provide answers about problems with insulin pumps -- and did not always inform them about their risks.

    The US Food and Drug Administration (FDA), which oversees such products, said that it should not be surprising that the leading producer of medical instruments would also be the subject of the largest number of complaints since it makes the most devices, the ICIJ noted.

    But in a lengthy article on its internet site, the consortium lists numerous cases in which Medtronic has been accused of legal or ethical breaches, either over debatable uses for its implants or for questionable relationships with doctors who use the products or who are behind favourable studies about them.

    In a written response to the ICIJ, a Medtronic spokesman, Rob Clark, insisted that patients' welfare was the company's top priority and that Medtronic respected "the highest standards of ethical practice."

    "Allegations are not facts and should not be interpreted to suggest that Medtronic violated our legal, ethical or regulatory obligations in any way," Clark said, while adding that any medical product carries a degree of risk.

    Medtronic makes devices to help control diabetes, manage chronic pain and alleviate Parkinson's disease and has invented the wireless pacemaker the size of a vitamin pill.

    The ICIJ credited the $400 medical device industry with developing lifesaving products while saying it had also "pushed against or broken legal and ethical boundaries."

    The Washington-based ICIJ brings together ad hoc collaborations of journalists from around the world to investigate issues of global interest. It won a Pulitzer Prize in 2017 for a series titled the "Panama Papers," an expose on offshore tax havens.



    Also Read: Medtronic reports 6 percent rise in quarterly revenue



    adverse eventsallegationdeathsicijimplant filesinsulin pumpsmedical deviceMedtronicmetronicpharmapharmaceuticalrob clarkUS firmus regulatorUSFDA
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok